Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Comparative Bioavailability Study of Clarithromycin 500 mg Tablets in Fed State

This study has been completed.
Sponsor:
Collaborator:
Genpharm ULC
Information provided by:
Mylan Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT00648128
First received: March 31, 2008
Last updated: NA
Last verified: February 2003
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2003
  Primary Completion Date: March 2003 (Final data collection date for primary outcome measure)